Risks of noncardiac surgery after coronary stenting.
An increased risk of major complications for noncardiac surgery after coronary stenting has been suggested. We retrospectively reviewed all cases of coronary stents from 1999 to 2003 with subsequent surgery to assess major adverse cardiovascular events (MACEs), including myocardial infarction, stent thrombosis, major bleeding, and death. Among the 56 patients identified, 8 developed MACEs; 38% underwent surgery < or =14 days after stenting, and 62% underwent surgery 15 to 42 days after stenting. No patient developed MACEs if surgery occurred >42 days after stenting. Among patients who developed MACEs, 77% of surgeries were elective, 19% were urgent, and only 4% were emergency. Noncardiac surgery 6 weeks after coronary stenting is associated with a high risk of MACEs.
Reddy
Proddutur R
PR
University of Illinois, Chicago, Illinois 60612, USA. dr_pasta@hotmail.com
Vaitkus
Paul T
PT
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000075202:Contraindications; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011183:Postoperative Complications / Q000401:mortality; D019106:Postoperative Hemorrhage / Q000401:mortality; D011474:Prosthesis Design; D012189:Retrospective Studies; D012306:Risk; D015607:Stents; D013514:Surgical Procedures, Operative / Q000401:mortality; D013997:Time Factors
D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin